PROTEINURIA THERAPEUTICS MARKET ANALYSIS

Proteinuria Therapeutics Market, by Drug Class (Angiotensin-converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Antagonists (ARBs), Diuretics, and Others), by Route of Administration (Oral and Intravenous), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI4491
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Proteinuria Therapeutics Market – Competitive landscape

Key players operating in the global proteinuria therapeutics market include GlaxoSmithKline plc, Chinook Therapeutics Inc., Novartis International AG, AbbVie Inc., Calliditas Therapeutics AB, Travere Therapeutics Inc., Walden Biosciences, Ligand Pharmaceuticals Inc., and Retrophin, Inc.